Skip to content

JBIO JBIO Total Operating Expenses

Total Operating Expenses at other companies

Vera Therapeutics logo
Vera TherapeuticsVERA
$125.13M+119%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$60.19M+8.8%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$53.7M-2.4%
Vor Biopharma logo
Vor BiopharmaVOR
$35.16M+5.6%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$116.31M+23.8%
Annexon logo
AnnexonANNX
$46.05M-19.8%

Other financials

Income statement

See full
Operating income-$43.4M-85.8%
Net income-$40.4M-5.8%
EPS (diluted)-$0.57+95.3%

Balance sheet

See full
Cash & equivalents$55.1M+24.6%
Total debt$808.0K+159%
Total equity$296.5M+455%
Total assets$319.4M+312%

Cash flow

See full
Operating cash flow-$24.1M-28.4%
CapEx$3.0K
Free cash flow-$33.7M

Valuation

See full
Market cap$1.33B+318%
Enterprise value$1.28B

Returns & leverage

See full
Return on equity-132.5%+120pp
Debt / equity
Current ratio14.3×-17.7×

Where this comes from

Reported directly by JBIO in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: JBIO’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about JBIO's total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is JBIO's total operating expenses?
JBIO (JBIO) reported total operating expenses of $43.45M in Q1 2026.
How has JBIO's total operating expenses changed year-over-year?
JBIO's total operating expenses increased by 85.8% year-over-year, from $23.38M to $43.45M.
What is the long-term trend for JBIO's total operating expenses?
Over 4 years (2021 to 2025), JBIO's total operating expenses has grown at a 49.0% compound annual growth rate (CAGR), from $23.02M to $113.54M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.